2018 | MD Anderson Cancer Center Skip to Content
Top

BY Scott Merville

Immunotherapy has taken hold as an effective treatment for a variety of advanced cancers, but so far, colorectal cancer has stubbornly resisted. 

However, research led by MD Anderson shows that resistance could be struck down. The recent international clinical trial helped expose a weak spot that leaves about 5% of colorectal tumors receptive to immune attack. (see the related story "5 years in, the Moon...

BY Scott Merville

Immune cells that rush to repair damage caused by inflammatory tissue are subverted to cancer-promoting allies by pancreas cells that feature...

BY Clayton R. Boldt, Ph.D.

Fewer than 30% of the women in the U.S. with abnormal, benign lesions known as atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS...

BY Clayton R. Boldt, Ph.D.

Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the incidence of cervical, oropharyngeal, anal, vulvar and vaginal cancers is increasing in the United States. 

MD Anderson’s HPV-Related Cancers Moon Shot™ is working to identify practical solutions and strategies to increase vaccination rates, improve screening and diagnostic options, and develop novel...

HPV vaccination

BY MD Anderson staff

“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research’s annual meeting, which...

BY Ron Gilmore

The American Association for Cancer Research (AACR) has selected Isaiah J. Fidler, D.V.M., Ph.D., professor of Cancer Biology, as recipient...

BY Scott Merville

Melanoma cells are able to evade cancer immunotherapy by using a specific protein to hide from immune system T cells out to seek and destroy...

BY Ronda Wendler

When people breathe, there’s movement inside their bodies.

Organs, tissues and even cancer patients’ tumors move around all the time...

BY Ron Gilmore

MD Anderson was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas (CPRIT), accounting for 30% of the $73.5...

BY Clayton Boldt, Ph.D.

MD Anderson’s Colorectal Cancer Moon Shot™ is committed to the prevention and early detection of the third most common cancer diagnosed in...

BY Ron Gilmore

Cell-based immunotherapies such as chimeric antigen receptors (CAR T), T-cell receptor (TCR) engineered T cells, tumor-infiltrating lymphocytes...

BY Bryan Tutt

Radiation therapy to the whole breast or chest wall and the internal mammary lymph nodes can deliver a radiation dose to the heart that increases...

BY Scott Merville

Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal...

BY Scott Merville

A cold virus engineered to attack the most common and deadly of brain tumors allowed 20% of patients with recurrent glioblastoma to live for...

BY Scott Merville

Organizations in Spain and Saudi Arabia recognized the leadership of Jim Allison, Ph.D., MD Anderson chair of Immunology, in cultivating the...

BY Scott Merville

A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared...

BY Ron Gilmore

Triple-negative breast cancer (TNBC), a highly aggressive, relapse-prone disease that accounts for one-fourth of all breast cancers, could...

BY Lany Kimmons

In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from MD Anderson Cancer...

BY Clayton Boldt, Ph.D.

Increasing the dosage of a prescription smoking cessation medication by 1 milligram a day – from 2 to 3 milligrams – more than doubled abstinence...

BY Joe Munch

Chemotherapy is a proven and effective method for treating many types of cancer, but up to 90% of patients who receive the treatment develop...

BY Clayton Boldt, Ph.D.

Older patients with non-metastatic breast cancer who have been treated modern chemotherapy drugs have a greater risk of secondary acute myeloid...

BY Sarah Bronson

Until recently, patients with esophageal cancer were treated with esophagectomy, or removal of the affected part of the esophagus and surrounding...

BY Ron Gilmore

A new genetic-based model developed by an MD Anderson research team may explain how a common form of early-stage breast cancer known as ductal...